Document is current
Any future updates will be listed below
-
Authors
Wagner, Josef
Harrison, Ewan M.
Martinez Del Pero, Marcos
Blane, Beth
Mayer, Gert
Leierer, Johannes
Gopaluni, Seerapani
Holmes, Mark A.
Parkhill, Julian
Peacock, Sharon J.
Jayne, David R. W.
Kronbichler, Andreas http://orcid.org/0000-0002-2945-2946
-
Funding
Funding for this research was provided by:
NIHR Cambridge Comprehensive Biomedical Research Centre Immunity, Infection and Inflammation theme (NA)
- License Information
-
More Information
Article History
Received: 9 November 2018
Accepted: 24 September 2019
First Online: 22 October 2019
Ethics approval and consent to participate
: The study was approved by the NRES Committee East of England – Cambridge Central. All participants approved to participate, and written informed consent was obtained.
: Not applicable.
: Gert Mayer received speaking and consulting fees from Böhringer Ingelheim, AbbVie, TEWA, Amgen, Novo Nordisk, Eli Lilly, Vifor and Otsuka. Mark A. Holmes received consultancy fees from Polypharmakos Ltd. and the Wellcome Trust. Sharon J. Peacock and Julian Parkhill received consulting fee from Next Gen Diagnostics. David R.W. Jayne received consulting fees from Astra-Zeneca, Böhringer Ingelheim, ChemoCentryx, GSK, Roche and Vifor. Andreas Kronbichler received speaking fees from Chugai, Miltenyi Biotech and TerumoBCT.
